As we continue to solidify our position as one of the leading certified medical cannabis facilities in Thailand, we are excited to share the next phase of our growth. We are currently nearing the completion of a new specialized mother room and a drying room, which are key components of our strategic roadmap to significantly expand our overall cultivation capacity.
This investment allows us to broaden our reach, providing consistent, high-quality medical products to patients and partners across various international markets. From our early decision to integrate medical expertise into our leadership to our current focus on EU GACP and EU GMP readiness, KAMBIS has always prioritized the clinical needs of the end-user. This expansion isn’t just about growing more; it is about ensuring that as we scale, the reliability and purity of our botanical medicine remain world-class.
Interested in securing your Q3 2026 supply? We invite our international partners to a formal consultation to discuss how our expanded production capacity can support your long-term requirements.